Structure of basic phospholipase A2 from Agkistrodon halys Pallas: Implications for its association, hemolytic and anticoagulant activities

Toxicon

Volumn 38, Issue 7, 2000, Pages 901-916

  Zhao, Kehao ^a   Zhou, Yuancong ^b   Lin, Zhengjiong ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

Crystal structure; Pharmacological activity; Venom phospholipase A2

Indexed keywords

ANTICOAGULANT AGENT; PHOSPHOLIPASE A2; VENOM;

AGKISTRODON HALYS; ANTICOAGULATION; ARTICLE; CRYSTAL STRUCTURE; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; LIGHT SCATTERING; NONHUMAN; PRIORITY JOURNAL;

AGKISTRODON; ANIMALS; BLOOD COAGULATION; CROTALID VENOMS; CRYSTALLOGRAPHY, X-RAY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEMOLYSIS; MODELS, MOLECULAR; MOLECULAR STRUCTURE; PHOSPHOLIPASES A; STRUCTURE-ACTIVITY RELATIONSHIP;

AGKISTRODON; GLOYDIUS HALYS; VERTEBRATA;

EID: 0033965390     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-0101(99)00193-2     Document Type: Article

References (48)

1. 2 from Vipera russelli snake venom by guanidination of lysine residues. Toxicon. 32:1994;749-752.
2. 2 on lipid bilayers. J. Biol. Chem. 267:(16):1992;11046-11056.
3. Brunger A.T. XPLOR Manual, version 3.1. 1992;Yale university, New Haven, CT.
4. Brunger A.T. Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature. 355:1992;472-475.
5. 2 at 2.5 Å: access to a shielded catalytic center. J. Biol. Chem. 260:1985;9742-9749.
6. 2. Toxicon. 36:1998;75-92.
7. 2: autocatalytic derivatization of the enzyme by acyl transfer from substrate. J. Biol. Chem. 263:1988;11237-11241.
8. 2. Toxicon. 19:1981;705-720.
9. 2: effects on enzymatic activity, lethality and some pharmacological properties. Toxicon. 21:1983;209-218.
10. 2. Nature. 289:1981;604-606.
11. 2 Enzymes: Structure, Function and Mechanism. 1997;353-360 John Wiley and Sons, KU.
12. 2-terminal lysines in action on phospholipids of Escherichia coli. Biochemistry. 25:1986;4309-4314.
13. Jones T.A. A graphics model building and refinement system for macromolecules. J. Appl. Cryst. 11:1978;268-272.
14. 2. J. Biol. Chem. 262:1987;14402-14407.
15. 2. Toxicon. 27:1989;613-635.
16. Kraulis P.J. MOLSCRIPT: a program to produce both detailed and schematic plots of proteins. J. Appl. Crystallog. 24:1991;946-950.
17. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
18. Laskowski R., Macarthur M., Moss D., Thornton J. Procheck: a program to check stereochemical quality of protein structures. J. Appl. Crystallog. 26:1993;283-290.
19. 2 -II from Agkistrodon halys Pallas. Biochim. Biophys. Acta. 1431:1999;157-165.
20. Luzzati P.V. Traitement statistique des erreurs dans la determination des structures cristallines. Acta Crystallog. 5:1952;802-810.
21. 2 on blood plasma and on a cell-free system is due to a phospholipid-independent mechanism of action involving the inhibition of factor Va. Eur. J. Biochem. 237:1996;778-785.
22. 2 involves binding to factor Xa. J. Biol. Chem. 273:1998;23764-23772.
23. Navaza J. AMoRe: an automated package for molecular replacement. Acta Cryst. A50:1994;157-163.
24. Nichols A., Sharp K., Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins. 11:1991;281-296.
25. 2 from the venom of Agkistrodon halys Pallas. Acta Biochem. Biophys. Sin. 28:1996;206-209.
26. 2 purified from Trimeresurus mucrosquamatus (Formosan habu) snake venom. Toxicon. 19:1981;113-120.
27. Otwinowski Z. Oscillation data reduction program. Sawyer L., Isaacs N., Bailey S. Proceedings of the CCP4 study weekend: collection and processing, 29-30 January 1993. 1993;56-62 SERC Daresbury Laboratory, Daresbury, UK.
28. 2 a fluorescence study of their binding to phospholipid vesicles correlation with their anticoagulant activities. J. Biol. Chem. 255:1980;7734-7739.
29. Ren H., Ji Y. Observation of polymerism and isomerism of β-agkistrodotoxin. Prog. Biochem. Biophys. 24:1997;522-526.
30. 2 from the snake venom of Agkistrodon halys Pallas in Zhejiang. Acta. Biochim. Biophys. Sin. 16:1984;603-609.
31. 2 by modification of carboxylate groups. Biochem. Pharmacol. 32:1983;3525-3530.
32. 2. Science. 250:1990;1541-1546.
33. 2 from inflammatory exudate. Science. 254:1991;1007-1010.
34. 2 of A. halys blomhoffii on human erythrocyte membranes: problems in interpretation of phospholipid location. Arch. Biochem. Biophys. 209:1981;668-676.
35. 2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism. Biochemistry. 29:1990;7742-7746.
36. 2-type presynaptic neurotoxin from Agkistrodon halys Pallas. J. Mol. Biol. 282:1998;1-11.
37. 2 complexed with a substrate-derived inhibitor. Nature. 347:1990;689-691.
38. 2. Eur. J. Biochem. 112:1980;25-32.
39. 2 from the venom of Agkistrodon halys Pallas at 2.0 Å resolution. J. Mol. Biol. 256:1996;669-676.
40. 2 by protein engineering into enzyme active against Escherichia coli treated with the bactericidal/permeability-increasing protein. J. Biol. Chem. 266:1991;4162-4167.
41. 2 at 2.2 Å resolution. Nature. 352:1991;79-82.
42. 2 from the snake venom of Agkistrodon halys Pallas in Zhejiang. Zool. Res. 4:1981;13-21.
43. Wu X.-F., Jiang Z.-P., Chen Y.-C. A comparison of three phospholipase from the venom of Agkistrodon halys Pallas. Acta Biochim. Biophys. Sin. 16:1984;664-671.
44. 2 modified by p-bromo-phenacyl-bromide. Toxicon. 36:1998;875-886.
45. 2 from Agkistrodon halys Pallas at 2.13Å resolution. . Acta. Cryst. D54:1998;510-521.
46. 2 from venom of Agkistrodon halys Pallas in orthorhombic crystal form I at 0.25 nm resolution. Sci. Chin. Ser. C. 42:1999;80-89.
47. 2 from the venom of Agkistrodon halys Pallas. J. Nat. Toxins. 5:1996;85-93.
48. Zhang Y., Lee W.H., Gao R., Xiong Y.L., Wang W.Y., Zhu S.W. Effects of Pallas' viper (Agkistrodon halys Pallas) venom on blood coagulation and characterization of a prothrombin activitor. Toxicon. 36:1998;143-152.